Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Advanced synthesis patent CN107721815A enables high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability for global buyers.
Novel patent CN116731087A offers high-yield Molnupiravir synthesis. Reduces toxic waste and enhances supply chain reliability for global pharmaceutical manufacturers.
Patent CN109912569B reveals a mild, high-yield route for Esomeprazole Magnesium. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN103936717B reveals a novel Delafloxacin intermediate synthesis with improved purity and yield for reliable pharmaceutical intermediates supply chains.
Novel 2-step synthesis for D-p-hydroxyphenylglycine methyl ester hydrochloride. Reduces cost and waste for amoxicillin production. High purity and yield.
Advanced synthesis of Ambroxol Hydrochloride via methyl anthranilate. High yield, green chemistry, and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN114605272A details a novel Nickel-catalyzed asymmetric hydrogenation route for (R)-Fluoxetine intermediates, offering significant cost reduction and high enantioselectivity for API manufacturing.
Discover the advanced preparation method of Obeticholic Acid via patent CN111138509B, offering high purity, reduced impurities, and scalable manufacturing for global supply chains.
Patent CN1376159A details a high-yield Etoposide synthesis using TMSOTf. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel fluoride-catalyzed cyanation patent reduces steps and waste. Reliable supply chain for high-purity benzonitrile derivatives for global pharmaceutical manufacturing.
Patent CN106554316A details a novel acid-catalyzed route for Olaparib intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN107810189A reveals a safer one-step route for high-purity Melflufen intermediates. Discover cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN112175007A reveals a green NBS-based synthesis for pitavastatin calcium intermediates, offering >99% purity and eliminating phosphorus wastewater for reliable supply.
Patent CN104030981A enables mild Ivacaftor synthesis. Reduces cost and environmental impact. Reliable supply chain for high-purity pharmaceutical intermediates.
Patent CN104030981A reveals mild condition synthesis for Ivacaftor intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN111153881A details a novel alumina-catalyzed route for flavoxate intermediates, offering high purity, reduced waste, and scalable manufacturing for global supply chains.
Patent CN1022629C details a robust synthesis for broad-spectrum cephalosporins. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel enzymatic method for high-purity L-tyrosine. Reduces impurities and simplifies supply chain for pharmaceutical intermediate manufacturing globally.
Novel refining method eliminates column chromatography for cisatracurium besilate ensuring high purity and scalable manufacturing for global supply chains.
Patent CN103298795A details a novel oxalate salt crystallization process for Letrozole intermediates, eliminating regioisomers and enabling scalable API manufacturing.